In human colon cancer, CD26 was identified as a novel marker for cancer stem cells, and injection of CD26+ cells into SCID mice resulted in the development of distant metastasis, indicating the metastatic capacity of the CD26+ cells [43]. The gene discussed is DPP4; the disease is cancer.